<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/4D643118-D00D-43C5-A6C4-6035292F169C"><gtr:id>4D643118-D00D-43C5-A6C4-6035292F169C</gtr:id><gtr:name>Novartis</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:department>Sir William Dunn Sch of Pathology</gtr:department><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/4D643118-D00D-43C5-A6C4-6035292F169C"><gtr:id>4D643118-D00D-43C5-A6C4-6035292F169C</gtr:id><gtr:name>Novartis</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/134CE54A-1A37-4392-B7FE-8D9BDE706957"><gtr:id>134CE54A-1A37-4392-B7FE-8D9BDE706957</gtr:id><gtr:firstName>Christoph</gtr:firstName><gtr:otherNames>Marcel</gtr:otherNames><gtr:surname>Tang</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=G0900888"><gtr:id>96B89A15-F209-4A7A-A6C9-77CC08E42442</gtr:id><gtr:title>Interactions between complement and Neisseria meningitidis</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0900888</gtr:grantReference><gtr:abstractText>N. meningitis is an important human pathogen feared by parents and medical practitioneers alike. Each year around half a million people across the globe are affected by this bacterium which is a leading cause of meningitis and septicaemia in children. 

Our challenge is to understand how the meningococcus escapes surveillance by our immune system to enter into the bloodstream where it causes disease and damage to infected individuals. 

The bacterium lives in constant contact with humans (usually in the nasal passage), so it is exquisitely adapted to cope with our immune system. One example of this is that the bacterium binds a human molecule called factor H (fH) very tightly to its surface which acts to switch off immune responses. Additionally the bacterium covers itself with direct copies of human structures to camoflague itself when in the body. 

Knowing the answer to how the bacterium avoids our immune responses would be enormously valuable for designing effective vaccines.

This project will examine how the bacterium avoids the complement system, a key aspect of human immunity in the nasal passages and the bloodstream. We know that complement is critical in protection against N. meningitidis as people who lack complement factors are at great risk from meningoccal infection, and all our measures of immunity are based on complement. 

We will examine how complement factors are recruited to the surface of the bacterium and how this impacts on the development of the typical skin rash and the rapid progression of meningococcal disease. 

This will also help identify novel vaccines and allow us to evaluate their ability to induce protection. It is already known that complement factors bind to vaccine candidates on several bacteria, including N. meningitidis and the leading cause of pneumonia, Streptococcus pneumoniae. Therefore determining complement binding sites on the meningococcus should lead to the discovery of further vaccine candidates.</gtr:abstractText><gtr:technicalSummary>Neisseria meningitidis remains a leading cause of bacterial sepsis and meningitis throughout the world. It is estimated that there are approximately 500,000 cases of meningococcal disease p.a., with around 50,000 deaths. The progression of meningococcal disease can be extremely rapid, with death occurring within hours of the onset of the illness in some instances, and a significant number of survivors are left with permanent disabilities including neurological deficits and/or loss of limbs. 

There remains an urgent need to understand the molecular basis of virulence of this important human pathogen, and to develop vaccines that are effective against a broad range of meningococcal strains. 

The goal of this application is to define the interaction between N. meningitidis and the complement system. The complement system is the most ancient component of the mammalian immune system and is vital for immunity against the meningococcus. Our initial studies will focus on the interaction between factor H, the main negative regulator of complement activation, and its receptor on the surface of N. meningitidis, factor H binding protein (fHbp), and will provide fundamental insights into the pathogenesis of meningococcal colonisation and disease. As fHbp is a component of meningococcal vaccines in current clinical trials, the knowledge and models generated during the course of this work will be translated into the development and assessment of novel vaccines against meningococcal disease. Furthermore, we will define the interaction between this important human pathogen and other complement factors, as this will provide further insights into mechanisms of immune evasion and might identify further vaccine candidates.</gtr:technicalSummary><gtr:fund><gtr:end>2015-07-31</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2010-08-02</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>3437496</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Sir William Dunn School of Pathology</gtr:department><gtr:description>Investigation into the role of fHbp in avoidance of complement mediated lysis</gtr:description><gtr:id>CBC7BA26-FEF3-412D-A08A-1ECBF5957D07</gtr:id><gtr:impact>Paper in Nature. Further MRC funding</gtr:impact><gtr:partnerContribution>Provided structural details to current research</gtr:partnerContribution><gtr:piContribution>We analysed binding of fH and its effect on the bacterium. Professor Lea's group analysed the structure of this interaction.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Novartis</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Vaccines and Diagnostics</gtr:department><gtr:description>Evaluation of vaccine candidates</gtr:description><gtr:id>B86964C1-8D83-4386-87A6-8CDDD4A9FA3D</gtr:id><gtr:impact>One manuscript submitted, one in preparation</gtr:impact><gtr:partnerContribution>Providing monoclonal antibodies and NMR for analysis of proteins</gtr:partnerContribution><gtr:piContribution>Understanding the basis of fHbp interactions with fH by mutagenesis of different variants of the bacterial protein.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Newspaper article on work</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:id>C8ABA23E-621F-43A6-9585-999B4B2F303F</gtr:id><gtr:impact>Research was featured in the Daily Telegraph and Dail Mail

Not certain</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Visit by school children</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>C1924414-EB40-4735-A92E-17CB8C6F9895</gtr:id><gtr:impact>We had around 30 children of between 9-10 yrs old in the Department to discuss the development of antibiotics

Not certain</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs><gtr:intellectualPropertyOutput><gtr:description>Our structural analysis allowed us to generate non functional fHbps as vaccines against meningococcal disease.</gtr:description><gtr:id>5887C51C-8CF9-4799-85DE-F08030BBEAC1</gtr:id><gtr:impact>Understanding the basis of the host pathogen interactions</gtr:impact><gtr:licensed>Yes</gtr:licensed><gtr:patentId>Insufficient Information</gtr:patentId><gtr:protection>Patent granted</gtr:protection><gtr:title>Non functional fHbps as vaccines</gtr:title></gtr:intellectualPropertyOutput></gtr:intellectualPropertyOutputs><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D0702452-0202-4F8F-9C2A-D4E9983BB070"><gtr:id>D0702452-0202-4F8F-9C2A-D4E9983BB070</gtr:id><gtr:title>Dry roasting enhances peanut-induced allergic sensitization across mucosal and cutaneous routes in mice.</gtr:title><gtr:parentPublicationTitle>The Journal of allergy and clinical immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/5ef2c0b1ca5456b75d8684c5f992ad47"><gtr:id>5ef2c0b1ca5456b75d8684c5f992ad47</gtr:id><gtr:otherNames>Moghaddam AE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0091-6749</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/4DC7337A-F6CD-4BD7-A7C9-F14532130AE6"><gtr:id>4DC7337A-F6CD-4BD7-A7C9-F14532130AE6</gtr:id><gtr:title>Structural basis for the recognition and cleavage of abasic DNA in Neisseria meningitidis.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b547807318acd5f0dc3ba27c7fe7636a"><gtr:id>b547807318acd5f0dc3ba27c7fe7636a</gtr:id><gtr:otherNames>Lu D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/381ECCEE-1E96-4340-8AD5-F7B3E5B17DAA"><gtr:id>381ECCEE-1E96-4340-8AD5-F7B3E5B17DAA</gtr:id><gtr:title>Temperature triggers immune evasion by Neisseria meningitidis.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/dfb00ddf802d408e11c9217b8a0712b0"><gtr:id>dfb00ddf802d408e11c9217b8a0712b0</gtr:id><gtr:otherNames>Loh E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/09DF1338-87A2-4866-BFDF-C2B087537B7B"><gtr:id>09DF1338-87A2-4866-BFDF-C2B087537B7B</gtr:id><gtr:title>The homo-oligomerisation of both Sas-6 and Ana2 is required for efficient centriole assembly in flies.</gtr:title><gtr:parentPublicationTitle>eLife</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/72f967ddd8bb3433d6513d9bea50597f"><gtr:id>72f967ddd8bb3433d6513d9bea50597f</gtr:id><gtr:otherNames>Cottee MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2050-084X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D9999832-D85D-4037-AF41-D9AFFB2B53A9"><gtr:id>D9999832-D85D-4037-AF41-D9AFFB2B53A9</gtr:id><gtr:title>ErpC, a member of the complement regulator-acquiring family of surface proteins from Borrelia burgdorferi, possesses an architecture previously unseen in this protein family.</gtr:title><gtr:parentPublicationTitle>Acta crystallographica. Section F, Structural biology and crystallization communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/547c49ebb78a8b00b254b568cfa5f4b6"><gtr:id>547c49ebb78a8b00b254b568cfa5f4b6</gtr:id><gtr:otherNames>Caesar JJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1744-3091</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/189DEA83-CC32-4EE9-BE23-4DD07321EB7E"><gtr:id>189DEA83-CC32-4EE9-BE23-4DD07321EB7E</gtr:id><gtr:title>A network of enzymes involved in repair of oxidative DNA damage in Neisseria meningitidis.</gtr:title><gtr:parentPublicationTitle>Molecular microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/918ec9251d5a82f95ebf5529c1377204"><gtr:id>918ec9251d5a82f95ebf5529c1377204</gtr:id><gtr:otherNames>Nagorska K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0950-382X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/74EAC0BE-0768-4812-A447-CE286EFFA22F"><gtr:id>74EAC0BE-0768-4812-A447-CE286EFFA22F</gtr:id><gtr:title>The role of the exopolyphosphatase PPX in avoidance by Neisseria meningitidis of complement-mediated killing.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/249808295c23f4d85591d33c08cc2225"><gtr:id>249808295c23f4d85591d33c08cc2225</gtr:id><gtr:otherNames>Zhang Q</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/8A381F4D-CD19-44B3-B93A-05934D0735DF"><gtr:id>8A381F4D-CD19-44B3-B93A-05934D0735DF</gtr:id><gtr:title>Galectin-3 binds Neisseria meningitidis and increases interaction with phagocytic cells.</gtr:title><gtr:parentPublicationTitle>Cellular microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ea134b2595b814da5ba065f5521c4255"><gtr:id>ea134b2595b814da5ba065f5521c4255</gtr:id><gtr:otherNames>Quattroni P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1462-5814</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D4FBC435-2A4F-4C94-8A6A-6301C2781288"><gtr:id>D4FBC435-2A4F-4C94-8A6A-6301C2781288</gtr:id><gtr:title>Specialization of an Exonuclease III family enzyme in the repair of 3' DNA lesions during base excision repair in the human pathogen Neisseria meningitidis.</gtr:title><gtr:parentPublicationTitle>Nucleic acids research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/665c4e66dee29c3553b47e57360737d4"><gtr:id>665c4e66dee29c3553b47e57360737d4</gtr:id><gtr:otherNames>Silhan J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0305-1048</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/A36D6FBF-7230-4DA0-9B65-0AB18F39FE40"><gtr:id>A36D6FBF-7230-4DA0-9B65-0AB18F39FE40</gtr:id><gtr:title>Structural basis for recognition of the pore-forming toxin intermedilysin by human complement receptor CD59.</gtr:title><gtr:parentPublicationTitle>Cell reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/353e752deb089a0d0e572cf98e705365"><gtr:id>353e752deb089a0d0e572cf98e705365</gtr:id><gtr:otherNames>Johnson S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/B73E513E-8FC0-4119-B43E-D52297747314"><gtr:id>B73E513E-8FC0-4119-B43E-D52297747314</gtr:id><gtr:title>Mechanism of thiosulfate oxidation in the SoxA family of cysteine-ligated cytochromes.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/175329c85c96ad22760e30f6f7ff7923"><gtr:id>175329c85c96ad22760e30f6f7ff7923</gtr:id><gtr:otherNames>Grabarczyk DB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/1A729BDE-54B8-44FF-973C-F546CC4EF556"><gtr:id>1A729BDE-54B8-44FF-973C-F546CC4EF556</gtr:id><gtr:title>Characterization of Neisseria meningitidis isolates that do not express the virulence factor and vaccine antigen factor H binding protein.</gtr:title><gtr:parentPublicationTitle>Clinical and vaccine immunology : CVI</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/53b8d67acc33b6174926a84776627a29"><gtr:id>53b8d67acc33b6174926a84776627a29</gtr:id><gtr:otherNames>Lucidarme J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1556-679X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/DF04CC43-F6DD-411F-9897-5C50747C44E3"><gtr:id>DF04CC43-F6DD-411F-9897-5C50747C44E3</gtr:id><gtr:title>Distinct binding and immunogenic properties of the gonococcal homologue of meningococcal factor h binding protein.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/48130fee6160a9f3afc2ad50855dc370"><gtr:id>48130fee6160a9f3afc2ad50855dc370</gtr:id><gtr:otherNames>Jongerius I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/17D30B86-1D83-4385-BC41-6B83B0619343"><gtr:id>17D30B86-1D83-4385-BC41-6B83B0619343</gtr:id><gtr:title>Nonfunctional variant 3 factor H binding proteins as meningococcal vaccine candidates.</gtr:title><gtr:parentPublicationTitle>Infection and immunity</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b9a6113e3c7e4888f8bd04e9c9ac800f"><gtr:id>b9a6113e3c7e4888f8bd04e9c9ac800f</gtr:id><gtr:otherNames>van der Veen S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0019-9567</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/09AAB55B-248B-4976-B5AB-268C60FC48B0"><gtr:id>09AAB55B-248B-4976-B5AB-268C60FC48B0</gtr:id><gtr:title>Identification of vaccine antigens using integrated proteomic analyses of surface immunogens from serogroup B Neisseria meningitidis.</gtr:title><gtr:parentPublicationTitle>Journal of proteomics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/2c1b247a4f72aa031fc0966736f27c27"><gtr:id>2c1b247a4f72aa031fc0966736f27c27</gtr:id><gtr:otherNames>Tsolakos N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1874-3919</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E0379945-7D4C-4CB3-9E36-231E0C3D625B"><gtr:id>E0379945-7D4C-4CB3-9E36-231E0C3D625B</gtr:id><gtr:title>Transcellular passage of Neisseria meningitidis across a polarized respiratory epithelium.</gtr:title><gtr:parentPublicationTitle>Infection and immunity</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/58c80b85ad021864c9bed5cd60822c64"><gtr:id>58c80b85ad021864c9bed5cd60822c64</gtr:id><gtr:otherNames>Sutherland TC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0019-9567</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D98AE25E-BFE3-4B46-BAA2-888EC0294264"><gtr:id>D98AE25E-BFE3-4B46-BAA2-888EC0294264</gtr:id><gtr:title>Design and evaluation of meningococcal vaccines through structure-based modification of host and pathogen molecules.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/353e752deb089a0d0e572cf98e705365"><gtr:id>353e752deb089a0d0e572cf98e705365</gtr:id><gtr:otherNames>Johnson S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/CEEDE6C2-974F-43A1-8FE8-0779D16C0E8C"><gtr:id>CEEDE6C2-974F-43A1-8FE8-0779D16C0E8C</gtr:id><gtr:title>Glutamate utilization promotes meningococcal survival in vivo through avoidance of the neutrophil oxidative burst.</gtr:title><gtr:parentPublicationTitle>Molecular microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/1f6ba1d838d96c5ae9f041a8a89e5090"><gtr:id>1f6ba1d838d96c5ae9f041a8a89e5090</gtr:id><gtr:otherNames>Tal? A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0950-382X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/57420BBE-9950-46E8-9A9A-C4DE6CF12DAD"><gtr:id>57420BBE-9950-46E8-9A9A-C4DE6CF12DAD</gtr:id><gtr:title>Thermoregulation of Meningococcal fHbp, an Important Virulence Factor and Vaccine Antigen, Is Mediated by Anti-ribosomal Binding Site Sequences in the Open Reading Frame.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/dfb00ddf802d408e11c9217b8a0712b0"><gtr:id>dfb00ddf802d408e11c9217b8a0712b0</gtr:id><gtr:otherNames>Loh E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/05CAAC0E-C5B3-4AAE-8267-13D8505F973B"><gtr:id>05CAAC0E-C5B3-4AAE-8267-13D8505F973B</gtr:id><gtr:title>Polymorphisms in the human inhibitory signal-regulatory protein a do not affect binding to its ligand CD47.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/49b18b8a2d6abc4fab7a4805d65e8c30"><gtr:id>49b18b8a2d6abc4fab7a4805d65e8c30</gtr:id><gtr:otherNames>Hatherley D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/9014D53E-4F99-428B-A855-88AF461BC6D3"><gtr:id>9014D53E-4F99-428B-A855-88AF461BC6D3</gtr:id><gtr:title>Structural basis for specificity and promiscuity in a carrier protein/enzyme system from the sulfur cycle.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/175329c85c96ad22760e30f6f7ff7923"><gtr:id>175329c85c96ad22760e30f6f7ff7923</gtr:id><gtr:otherNames>Grabarczyk DB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/B304B0FE-32F2-4EE6-95A4-4558A9DA463F"><gtr:id>B304B0FE-32F2-4EE6-95A4-4558A9DA463F</gtr:id><gtr:title>Competition between antagonistic complement factors for a single protein on N. meningitidis rules disease susceptibility.</gtr:title><gtr:parentPublicationTitle>eLife</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/547c49ebb78a8b00b254b568cfa5f4b6"><gtr:id>547c49ebb78a8b00b254b568cfa5f4b6</gtr:id><gtr:otherNames>Caesar JJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2050-084X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/B8DD8BD0-2990-4B09-9E84-14BDFB61BA6D"><gtr:id>B8DD8BD0-2990-4B09-9E84-14BDFB61BA6D</gtr:id><gtr:title>Putting the structure into complement.</gtr:title><gtr:parentPublicationTitle>Immunobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/90f73766dd76f890ba0e6f6e4e951a68"><gtr:id>90f73766dd76f890ba0e6f6e4e951a68</gtr:id><gtr:otherNames>Lea SM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0171-2985</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/1E61109C-518F-4607-A9BA-FB90F655DAA9"><gtr:id>1E61109C-518F-4607-A9BA-FB90F655DAA9</gtr:id><gtr:title>Structure of the TatC core of the twin-arginine protein transport system.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ed4075e4c6deda633df1a58fff611f0f"><gtr:id>ed4075e4c6deda633df1a58fff611f0f</gtr:id><gtr:otherNames>Rollauer SE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/3C44DAED-A001-463A-8B62-0DD1B69C6B25"><gtr:id>3C44DAED-A001-463A-8B62-0DD1B69C6B25</gtr:id><gtr:title>Biochemical analysis of the Plasmodium falciparum erythrocyte-binding antigen-175 (EBA175)-glycophorin-A interaction: implications for vaccine design.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/fd5d1ea0da16beba4811129efd240a11"><gtr:id>fd5d1ea0da16beba4811129efd240a11</gtr:id><gtr:otherNames>Wanaguru M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E6B5C08C-8341-48A8-9A97-1CC9483A4B86"><gtr:id>E6B5C08C-8341-48A8-9A97-1CC9483A4B86</gtr:id><gtr:title>Structures of CD200/CD200 receptor family and implications for topology, regulation, and evolution.</gtr:title><gtr:parentPublicationTitle>Structure (London, England : 1993)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/49b18b8a2d6abc4fab7a4805d65e8c30"><gtr:id>49b18b8a2d6abc4fab7a4805d65e8c30</gtr:id><gtr:otherNames>Hatherley D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0969-2126</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/7EBEF36D-8985-48EC-80CB-867159A2FCEA"><gtr:id>7EBEF36D-8985-48EC-80CB-867159A2FCEA</gtr:id><gtr:title>Mechanisms of meningococcal colonisation.</gtr:title><gtr:parentPublicationTitle>Trends in microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/8e99229cece7f6f8b7f3a04314791b55"><gtr:id>8e99229cece7f6f8b7f3a04314791b55</gtr:id><gtr:otherNames>Trivedi K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0966-842X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/FE978D1F-9BD3-47F2-A4E6-8B8F659D492F"><gtr:id>FE978D1F-9BD3-47F2-A4E6-8B8F659D492F</gtr:id><gtr:title>Architecture of the major component of the type III secretion system export apparatus.</gtr:title><gtr:parentPublicationTitle>Nature structural &amp; molecular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f66fef42bf57f21c35f55f49c5783d66"><gtr:id>f66fef42bf57f21c35f55f49c5783d66</gtr:id><gtr:otherNames>Abrusci P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1545-9985</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/75A0952F-BCDE-41FB-8A4C-7520FC9E0764"><gtr:id>75A0952F-BCDE-41FB-8A4C-7520FC9E0764</gtr:id><gtr:title>Characterisation of Shigella Spa33 and Thermotoga FliM/N reveals a new model for C-ring assembly in T3SS.</gtr:title><gtr:parentPublicationTitle>Molecular microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/33eed3282e1315f1f217059dd1a1bdc8"><gtr:id>33eed3282e1315f1f217059dd1a1bdc8</gtr:id><gtr:otherNames>McDowell MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0950-382X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/89E9F133-4327-440D-B4F1-377905C79A67"><gtr:id>89E9F133-4327-440D-B4F1-377905C79A67</gtr:id><gtr:title>Building a secreting nanomachine: a structural overview of the T3SS.</gtr:title><gtr:parentPublicationTitle>Current opinion in structural biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f66fef42bf57f21c35f55f49c5783d66"><gtr:id>f66fef42bf57f21c35f55f49c5783d66</gtr:id><gtr:otherNames>Abrusci P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0959-440X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/277E9ED1-C6DA-410C-949C-5CD4D58B9918"><gtr:id>277E9ED1-C6DA-410C-949C-5CD4D58B9918</gtr:id><gtr:title>The centrosome-specific phosphorylation of Cnn by Polo/Plk1 drives Cnn scaffold assembly and centrosome maturation.</gtr:title><gtr:parentPublicationTitle>Developmental cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/aa37936c00cf1bb28c98b7c73d7e7784"><gtr:id>aa37936c00cf1bb28c98b7c73d7e7784</gtr:id><gtr:otherNames>Conduit PT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1534-5807</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/53FD54FB-5890-433D-84EA-9DB78F205A9B"><gtr:id>53FD54FB-5890-433D-84EA-9DB78F205A9B</gtr:id><gtr:title>Crystal structure of the Bacillus subtilis phosphodiesterase PhoD reveals an iron and calcium-containing active site.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c75776bc1f93ee17c94bece20dfdcb21"><gtr:id>c75776bc1f93ee17c94bece20dfdcb21</gtr:id><gtr:otherNames>Rodriguez F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/6E734C88-CB36-4EF4-8426-95F08A33692D"><gtr:id>6E734C88-CB36-4EF4-8426-95F08A33692D</gtr:id><gtr:title>Crystal structures of the CPAP/STIL complex reveal its role in centriole assembly and human microcephaly.</gtr:title><gtr:parentPublicationTitle>eLife</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/72f967ddd8bb3433d6513d9bea50597f"><gtr:id>72f967ddd8bb3433d6513d9bea50597f</gtr:id><gtr:otherNames>Cottee MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>2050-084X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/47A81F9B-F92C-456D-A4DE-25E73EE26BD9"><gtr:id>47A81F9B-F92C-456D-A4DE-25E73EE26BD9</gtr:id><gtr:title>New insights into pathogen recognition.</gtr:title><gtr:parentPublicationTitle>Expert review of anti-infective therapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ea134b2595b814da5ba065f5521c4255"><gtr:id>ea134b2595b814da5ba065f5521c4255</gtr:id><gtr:otherNames>Quattroni P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1478-7210</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/F63E8207-4E97-4E2B-A633-6D8C3EB9BFC6"><gtr:id>F63E8207-4E97-4E2B-A633-6D8C3EB9BFC6</gtr:id><gtr:title>Two cross-reactive monoclonal antibodies recognize overlapping epitopes on Neisseria meningitidis factor H binding protein but have different functional properties.</gtr:title><gtr:parentPublicationTitle>FASEB journal : official publication of the Federation of American Societies for Experimental Biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/49e8123e55a90c465704279fd5f4b533"><gtr:id>49e8123e55a90c465704279fd5f4b533</gtr:id><gtr:otherNames>Faleri A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0892-6638</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0900888</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>C6D70A71-8796-47BC-AFE0-CC2286E66A06</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Inflammatory and Immune System</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>